Graft-versus-host disease (GVHD) is a medical condition that can occur after a stem cell or bone marrow transplant. In this condition, the donor's immune cells (graft) attack the recipient's cells (host) leading to a variety of symptoms. GVHD can occur in both acute and chronic forms and can affect different parts of the body, including the skin, liver, and gastrointestinal tract.
The symptoms of GVHD can vary depending on the severity of the condition and the organs affected. Some common symptoms of acute GVHD include:
Chronic GVHD symptoms can persist for several months or years and may include:
The treatment of GVHD depends on the severity of the condition and the organs affected. In mild cases, the symptoms can be managed with medications such as corticosteroids, immunosuppressants, and antibiotics. In severe cases, hospitalization may be required, and treatment may involve high-dose steroid therapy, photopheresis, and other immunosuppressive drugs. In some cases, a second stem cell transplant may be necessary.
It is essential to monitor the symptoms of GVHD carefully and seek medical attention if any new symptoms develop. Early detection and treatment of GVHD can improve the chances of a successful outcome after a stem cell or bone marrow transplant.
Graft-versus-host disease is a severe medical condition that can occur after a stem cell or bone marrow transplant. The symptoms can vary depending on the severity of the condition and the organs affected. It is essential to seek medical attention if any symptoms develop, as early detection and treatment can improve the chances of a successful outcome.